Journals / Türk Dermatoloji Dergisi / 2017 / Cilt: 11 - Sayı: 4

Erişkin Dermatoloji Hastalarının Aşılanması

Vaccinations in Adult Dermatology Patients

Pages
28–35
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As every encounter with a patient is an opportunity to advise appropriate immunizations, this review focuses on immunizing adult dermatology patients with special emphasis on the patients using immunosuppressive treatments

📌 3 Key Takeaways

🎯
Objective & Hypothesis:It is known that, susceptibility to infections may increase in dermatologic diseases due to the disease itself or the immunosuppressive/immunomodulatory treatments used.
📊
Key Findings & Data:In dermatology, these kinds of drugs are frequently incorporated into the treatments of patients with psoriasis, pemphigus, bullous pemphigoid and other autoimmune bullous diseases.
💡
Conclusion & Impact:As every encounter with a patient is an opportunity to advise appropriate immunizations, this review focuses on immunizing adult dermatology patients with special emphasis on the patients using immunosuppressive treatments
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

It is known that, susceptibility to infections may increase in dermatologic diseases due to the disease itself or the immunosuppressive/immunomodulatory treatments used. In clinical practice, many treatment options are used in chronic diseases, ranging from the long-standing, well-known immunosuppressive therapies to the numerous biological agents that have come into use in recent years. In dermatology, these kinds of drugs are frequently incorporated into the treatments of patients with psoriasis, pemphigus, bullous pemphigoid and other autoimmune bullous diseases. Although many infections are vaccine preventable, the importance of vaccines in adult dermatology patients undergoing such treatments is not sufficiently known. As every encounter with a patient is an opportunity to advise appropriate immunizations, this review focuses on immunizing adult dermatology patients with special emphasis on the patients using immunosuppressive treatments

Özet

Dermatolojik hastalıklarda enfeksiyonlara eğilimin hastalığa ve kullanılan immunosüpresif ve immünomodülatuar tedavilere bağlı arttığı bilinmektedir. Klinik uygulamalarda, eskiden beri var olan, iyi bilinen immunosüpresan tedavilerden son yıllarda kullanım alanına giren çok sayıda biyolojik ajana kadar birçok tedavi seçeneği kronik hastalıklarda kullanılmaktadır. Dermatolojide bu grup tedavilerin sık kullanımına en iyi örnekler psoriasis ve pemfigus ve büllöz pemfigoid gibi otoimmün büllöz hastalıklardır. Her ne kadar birçok enfeksiyon aşı ile önlenebilir olsa da dermatolojide bu tedavilerin kullanıldığı hasta gruplarında immünizasyonun yeri yeterince bilinmemektedir. Hastayla her karşılaşma, gereksinim duyduğu aşıları önermek için bir fırsat olduğundan bu gözden geçirme yazısında erişkin dermatoloji hastalarının, özellikle de bağışıklığı baskılayıcı ilaç kullananların bağışıklanmasına değinilecektir

🔖

Cite This Article

VELİPAŞAOĞLU, S., DİCLE, Ö. (2022). Erişkin Dermatoloji Hastalarının Aşılanması. Türk Dermatoloji Dergisi, Cilt: 11 - Sayı: 4, 28–35. https://ajindex.com/articles/621601

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Blank PR, Schwenkglenks M, Szucs TD. Vaccination coverage rates in eleven European countries during two consecutive influenza seasons. J Infect 2009;58:446-58
  2. Mazzola G, Macaluso FS, Adamoli L, et al. Diagnostic and vaccine strategies to prevent infections in patients with inflamatory bowel disease. J Infect 2017;74:433-41
  3. Dipasquale V, Romano C. Vaccination strategies in pediatric inflammatory bowel disease. Vaccine 2017;35:6070-5
  4. Wine-Lee L, Keller SC, Wilck MB, et al. From the Medical Board of the National Psoriasis Foundation:Vaccination in adult patients on systemic therapy for psoriasis. J Am Acad Dermatol 2013;69:1003-13
  5. Kader C, Kara M, Göçmen AY, et al. Antibodies against vaccine preventable diseases in pregnant women measles, mumps, rubella, varicella and tetanus in Yozgat, Turkey. Konuralp Medical Journal 2017;9:29-34
  6. Kose S, Mandiracioglu A, Senger SS, et al. Seroprevalence of varicella-zoster virus in the prevaccine era: a population based study in Izmir, Turkey. J Infect Public Health 2013;6:115-9
  7. Demiray T, Köroğlu M, Jacobsen KH, et al. Hepatitis A virus epidemiology in Turkey as universal childhood vaccination begins: seroprevalence and endemicity by region. Turk J Pediatr 2016;58:480-91
  8. Tanriover MD, Soyler C, Ascioglu S, et al. Low seroprevalance of diphtheria, tetanus and pertussis in ambulatory adult patients: the need for lifelong vaccination. Eur J Intern Med 2014;25:528-32
  9. Erişkin bağışıklama kılavuzu. Available from http://ekmud.org.tr/e-akademi/ rehberler/ 10. American Academy of Pediatrics. Active immunization. In: Kimberlin DW, editor. 2015 Red Book: Report of the committee on infectious diseases. 30rd ed. Elk grove Village, IL: American Academy of Pediatrics; 2015. p.13-57
  10. Advisory Committee on Immunization Practices (ACIP). General recommendations on immunization. MMWR 2011;60:3-60
  11. Centers for Disease Control and Prevention. General recommendations on immunizations. In: Hamborsky J, Kroger A, Wolfe S, editors. 2015 Pink Book: Epidemiology and Prevention of Vaccine-Preventable Diseases. 13th ed. Washington D.C: Public Health Foundation; 2015. p.9-32
  12. Gunes AT, Fetil E, Akarsu S, et al. Possible triggering effect of influenza vaccination on psoriasis. J Immunol Res 2015;2015:258430
  13. Lopez A, Mariette X, Bachelez H, et al. Vaccination recommendations for the adult immunosuppressed patient: a systematic review and comprehensive field synopsis. J Autoimmun 2017;80:10-27